BRAF and MEK inhibitors rechallenge after an adverse drug reaction in patients with cancer: A pharmacovigilance cohort study
Title: | BRAF and MEK inhibitors rechallenge after an adverse drug reaction in patients with cancer: A pharmacovigilance cohort study |
---|---|
Authors: | Ezine, Emilien a, b, Da Silva, Angélique c, d, Idoudi, Safa a, Lebbe, Céleste a, b, Chrétien, Basile e, Sassier, Marion c, Alexandre, Joachim f, Dolladille, Charles f, * |
Source: | In Therapies December 2024 |
Database: | ScienceDirect |
ISSN: | 00405957 |
---|---|
DOI: | 10.1016/j.therap.2024.12.011 |
Published in: | Therapies |
Language: | English |